Literature DB >> 8490828

Role of mediastinoscopy in superior vena cava obstruction.

M Jahangiri1, D P Taggart, P Goldstraw.   

Abstract

BACKGROUND: The role of mediastinoscopy in superior vena cava obstruction (SVCO) is not clearly defined. The authors set out to examine the efficacy and safety of mediastinoscopy in SVCO.
METHODS: They reviewed 14 patients referred to one surgical team over an 8-year period (1982-1990) who required mediastinoscopy to establish a histologic diagnosis after other less invasive procedures had not established the diagnosis.
RESULTS: Of the 14 patients, 11 had lung cancer, 2 had lymphoma, and 1 had malignant thymoma. Definitive tissue diagnosis was obtained in 13 cases. Mediastinoscopy was unsuccessful in one of the cases because no pathologic tissue could be identified at the time of the procedure. Tissue diagnosis could only be obtained in this patient after mediastinotomy, and a lymphoma was found. There was one complication of mediastinoscopy; one patient had arterial bleeding from the innominate artery that required limited sternotomy to control the bleeding.
CONCLUSIONS: The authors believe that mediastinoscopy is a safe and effective technique for establishing a histologic diagnosis in SVCO when less invasive techniques have been unsuccessful. The use of blind radiation therapy cannot be justified on an emergency basis; failure to obtain a histologic diagnosis will result in up to 20% of patients receiving inappropriate radiation therapy, making subsequent tissue diagnosis very difficult.

Entities:  

Mesh:

Year:  1993        PMID: 8490828     DOI: 10.1002/1097-0142(19930515)71:10<3006::aid-cncr2820711019>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

Review 1.  [Compression syndromes].

Authors:  J Wierecky; C Bokemeyer
Journal:  Internist (Berl)       Date:  2005-01       Impact factor: 0.743

Review 2.  Stenting of superior vena caval obstruction.

Authors:  J E Jackson; D M Brooks
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

Review 3.  Superior vena cava syndrome.

Authors:  L J Wudel; J C Nesbitt
Journal:  Curr Treat Options Oncol       Date:  2001-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.